Lifecore Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LFCR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
03 Oct 24	BuyUS$5,999,997	Legion Partners Asset Management, LLC	Company		1,463,414	US$4.10
03 Oct 24	BuyUS$1,197,950	Wynnefield Capital, Inc.	Company		292,183	US$4.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LFCR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,619,260	7.11%
General Public	10,516,288	28.6%
Institutions	10,892,314	29.6%
Hedge Funds	12,799,168	34.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.5%.

Top Shareholders

Top 25 shareholders own 67.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.8%	Wynnefield Capital, Inc.	4,703,216	US$34.1m	-4.39%	14.96%
12%	Legion Partners Asset Management, LLC	4,403,754	US$31.9m	48.4%	11.28%
10%	Greenhaven Road Investment Management, LP	3,692,198	US$26.7m	65.7%	9.11%
4.77%	22NW, LP	1,755,161	US$12.7m	0%	8.55%
4.49%	David Capital Partners LLC	1,655,000	US$12.0m	0%	29.64%
4.11%	BlackRock, Inc.	1,512,946	US$11.0m	4.15%	no data
3.57%	The Vanguard Group, Inc.	1,315,216	US$9.5m	1.95%	no data
1.84%	James Hall	677,949	US$4.9m	53.3%	no data
1.8%	Morgan Stanley, Investment Banking and Brokerage Investments	663,893	US$4.8m	5.45%	no data
1.62%	Geode Capital Management, LLC	597,685	US$4.3m	10.3%	no data
1.47%	Paul Josephs	542,717	US$3.9m	3,290%	no data
1.27%	John Morberg	467,240	US$3.4m	130%	no data
1.18%	Albert Bolles	434,883	US$3.1m	0%	no data
0.91%	State Street Global Advisors, Inc.	334,360	US$2.4m	10.2%	no data
0.86%	Deutsche Asset & Wealth Management	315,719	US$2.3m	0%	no data
0.78%	Dcf Advisers, Llc	288,478	US$2.1m	-0.76%	1.07%
0.54%	Marshall Wace LLP	200,700	US$1.5m	-33.1%	no data
0.53%	Northern Trust Global Investments	193,479	US$1.4m	169%	no data
0.51%	Boothbay Fund Management, LLC	187,146	US$1.4m	1,430%	0.04%
0.41%	Tocqueville Asset Management LP	151,700	US$1.1m	0%	0.02%
0.39%	272 Capital LP	143,480	US$1.0m	511%	0.54%
0.35%	Quinn Opportunity Partners LLC	127,904	US$926.0k	18.5%	0.08%
0.31%	Eaton Vance Management	112,797	US$816.7k	-3.31%	no data
0.29%	GAMCO Investors, Inc.	105,500	US$763.8k	4.98%	no data
0.26%	Qube Research & Technologies Ltd	94,376	US$683.3k	15.8%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 05:09
End of Day Share Price	2024/12/20 00:00
Earnings	2024/08/25
Annual Earnings	2024/05/26

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lifecore Biomedical, Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alexander Paris	Barrington Research Associates, Inc.
Michael Petusky	Barrington Research Associates, Inc.
Matthew Hewitt	Craig-Hallum Capital Group LLC